Table 3 Characteristics of the prescribed drugs
From: Polypharmacy in a hospitalized psychiatric population: risk estimation and damage quantification
Drugs | Mean (SD) |
|---|---|
General drugs | 3.87 (2.3) |
Psychotropic drugs | 4.07 (1.9) |
Total drugs (no incidences) | 7.88 (3.4) |
Total drugs (incidents included) | 8.64 (4.1) |
Dosage of equivalent antipsychotic in milligrams of risperidone | 5.08 (2.97) |
Amount of prescribed drugs | Frequency (%) |
Less than 6 drugs | 26 (18.6) |
6 or more drugs | 114 (81.4) |
Psychotropic drugs | Frequency (%) |
Antipsychotic (AP) | 138 (98.5) |
Benzodiazepines | 126 (90) |
Mood stabilizer | 58 (41.4) |
Antidepressant | 39 (27.8) |
Antiparkinsonian | 19 (13.5) |
Antipsychotic type | Frequency (%) |
Risperidone | 47 (33.6) |
Olanzapine | 32 (22.9) |
Haloperidol decanoate | 24 (17.1) |
Haloperidol | 18 (12.9) |
Aripiprazol | 5 (3.6) |
Clozapine | 3 (2.1) |
Deposit Zuclopenthixol | 3 (2.1) |
Deposit Risperidone | 2 (1.4) |
Quetiapine | 2 (1.4) |
Zuclopentixol | 1 (0.7) |
Trifluoperazine | 1 (0.7) |
Antipsychotic combination and side effects | Frequency (%) |
Polypharmacy with antipsychotics | 20 (14.2) |
Side effects due to the use of drugs | 41 (29.2) |
Presence of extrapyramidal effects | 25 (17.8) |